Late breaking oral presentation will provide additional detail around previously reported top-line results LONDON, Sept. 12, 2018 (GLOBE...
Publication demonstrates RPL554's significant bronchodilation effect, in both large and small airways, alone and when combined with...
LONDON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
Significant progress with RPL554 as potential treatment for COPD and CF Recently initiated important Phase 2 trial as add-on to dual...
News) - Verona Pharma PLC said Wednesday that it started the second phase of a clinical trial of its nebulized RPL554 ...
This three-way crossover study will inform design of pivotal Phase 3 trials Top line data expected first quarter 2019 LONDON, Aug. 01, 2018...
Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2018 and Provide Clinical Development Update LONDON, July 26, 2018 (GLOBE...
LONDON, July 24, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
LONDON, June 26, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP.L), a clinical-stage biopharmaceutical company focused on developing and...
LONDON, June 4, 2018 (GLOBE NEWSWIRE) - Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma" or the "Company"), a...
LONDON, May 31, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
LONDON, May 30, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
Shareholders' Circular and Notice of General Meeting LONDON, May 23, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA...
Achieved statistically significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action in COPD...
LONDON, May 09, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.